Glycitein

ID15
NameGlycitein
Synonyms
StructureThumb
Description
GroupPolyphenols
Sub-groupIsoflavones
Exposure sourceDiet
Use
CAS number40957-83-3
PubChem ID5317750
ChEBI ID34778
FooDB IDFDB000698
HMDB IDHMDB05781

Biomarker measurements

Biomarker concentration values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionBiospecimenAnalytical methodBiomarkerBiomarker detailMeasurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
71771Quartile 1 (Isoflavone intake: 0.06 to 3.67 mg/day)Pubertal girlsKorea, Republic ofKRUrine, overnightLC-MS after enzymatic hydrolysisGlycitein120.5nmol/mg0.5 umol/gDensityCreatinineKim 2010
80851Quartile 4 (Isoflavone intake: 9.29 to 51.59 mg/day)Pubertal girlsKorea, Republic ofKRUrine, overnightLC-MS after enzymatic hydrolysisGlycitein121.3nmol/mg1.3 umol/gDensityCreatinineKim 2010
1100AllWomen in a high-risk program for breast or ovarian cancerUnited StatesUSFRAP (Family Risk Assessment Program)Urine, 24-hGC-MS after enzymatic hydrolysisGlycitein2742.684.23.616.239.9ng/mg42.6 ug/g16.2 ug/gDensityCreatinineTseng 2008
1150AllWomen in a high-risk program for breast or ovarian cancerUnited StatesUSFRAP (Family Risk Assessment Program)Urine, overnightGC-MS after enzymatic hydrolysisGlycitein2758.1139.33.311.144.6ng/mg58.1 ug/g11.1 ug/gDensityCreatinineTseng 2008
252425211AllMidle-aged and elderly womenChinaCNSWHS (Shanghai Women's Health Study)Urine, spotLC-MS/MS after enzymatic hydrolysisGlycitein21650.810.0090.0520.0980.320.942.535.358.2291.290.760.87nmol/mg0.8 umol/g0.9 umol/gDensityCreatinineWu 2012
479948121AllCases and controls in a case-control study on breast cancer and dietUnited KingdomGBEPIC-Norfolk (European Prospective Investigation into Cancer and Nutrition)Urine, spotGC-ID-MS after enzymatic hydrolysisGlycitein3332.92.40.82.56.356.0ug/mmol2900.0 ug/mol2500.0 ug/molDensityCreatinineGrace 2004
480648141AllCases and controls in a case-control study on breast cancer and dietUnited KingdomGBEPIC-Norfolk (European Prospective Investigation into Cancer and Nutrition)Serum, unspecifiedLC-ID-MS/MS after enzymatic hydrolysisGlycitein2840.11.20.00.10.21.2ng/mL0.0 mg/L0.0 mg/LCrudeGrace 2004
781378101ChinesesWomen from two large mammography clinics in HonoluluUnited StatesUS1 dayUrine, overnightHPLC after enzymatic hydrolysisGlycitein1324.034.0nmol/h0.6 umol/dayCrudeMaskarinec 1998
782078171FilipinosWomen from two large mammography clinics in HonoluluUnited StatesUS1 dayUrine, overnightHPLC after enzymatic hydrolysisGlycitein74.08.0nmol/h0.1 umol/dayCrudeMaskarinec 1998
782778241Native HawaiiansWomen from two large mammography clinics in HonoluluUnited StatesUS1 dayUrine, overnightHPLC after enzymatic hydrolysisGlycitein1120.049.0nmol/h0.5 umol/dayCrudeMaskarinec 1998
783478311JapanesesWomen from two large mammography clinics in HonoluluUnited StatesUS1 dayUrine, overnightHPLC after enzymatic hydrolysisGlycitein2588.0186.0nmol/h2.1 umol/dayCrudeMaskarinec 1998
784178381CaucasiansWomen from two large mammography clinics in HonoluluUnited StatesUS1 dayUrine, overnightHPLC after enzymatic hydrolysisGlycitein4214.036.0nmol/h0.3 umol/dayCrudeMaskarinec 1998
784878451OthersWomen from two large mammography clinics in HonoluluUnited StatesUS1 dayUrine, overnightHPLC after enzymatic hydrolysisGlycitein48.017.0nmol/h0.2 umol/dayCrudeMaskarinec 1998

Intake values

IDParent IDDepthSubject groupPopulationCountryCountry codeCohortTime definitionIntake toolIntake food coverageIntake time coverageIntake assessmentCompoundCompound detailSupplement intakes included?Measurement sizeDetected (nb)Detected (%)Detected only?Arithmethic meanArithmethic SDGeometric meanGeometric SDMinMin (detected)Percentile_05Percentile_10Percentile_25MedianPercentile_75Percentile_90Percentile_95MaxInterquartile rangeMean 95% CI lowerMean 95% CI upperGMean 95% CI lowerGMean 95% CI upperUnitConverted arithmetic meanConverted geometric meanConverted medianAdjustment typeAdjusted onRegressed onExpressed asPublication
63681Quartile 1 (Isoflavone intake: 0.06 to 3.67 mg/day)Pubertal girlsKorea, Republic ofKRDietary record (3-day)Glycitein120.30.1mg/day0.3 mg/dayCrudeKim 2010
67641Quartile 4 (Isoflavone intake: 9.29 to 51.59 mg/day)Pubertal girlsKorea, Republic ofKRDietary record (3-day)Glycitein121.81.2mg/day1.8 mg/dayCrudeKim 2010
7067071AllGeneral adult populationUnited StatesUSNHANES 1999-200224-h Dietary recall (1-day)Glycitein29080.10.0mg/day0.1 mg/dayCrudeChun 2009
7107111AllGeneral adult populationUnited StatesUSNHANES 1999-200224-h Dietary recall (1-day)Glycitein29080.10.0mg/1000 kcal0.1 mg/1000 kcalDensityEnergyChun 2009

Correlation values

Reproducibility values

No data available